To amend the Federal Food, Drug, and Cosmetic Act to authorize requiring the manufacturers of a covered device to disclose to a patient all patient-specific data that is recorded or transmitted by the device and accessible to the manufacturer, and for other purposes.
HR 6117 requires medical device makers to disclose all patient-specific data their devices collect and transmit to manufacturers, increasing transparency of health data practices.